Navigation Links
Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
Date:2/27/2008

llion, the majority of which are derived from the three largest markets; France, the United Kingdom and Germany.

Revenues from Asia Pacific were $170.9 million for the three months ended December 31, 2007 and were derived from Mylan's newly acquired operations in Australia, Japan and New Zealand.

For the Specialty Segment, total revenues for the three months ended December 31, 2007 were $102.1 million. The Specialty Segment consists of the Dey business that focuses on the development, manufacturing and marketing of specialty pharmaceuticals in the respiratory and severe allergy markets.

The Matrix Segment reported total revenues of $107.1 million, of which $92.9 million represents sales to third parties.

Gross profit for the three months ended December 31, 2007 was $356.1 million and gross margins were 30.8%. The decrease in gross margins is due primarily to the effects of purchase accounting items recorded during the quarter of approximately $117.7 million, which consisted primarily of amortization related to purchased intangible assets and the amortization of the inventory step-up associated with the acquisition of Merck Generics. Excluding such items, gross margins were 41.0% compared to 55.9% for the three months ended December 31, 2006.

The Company reported a loss from operations of $1.27 billion for the three months ended December 31, 2007. This loss from operations for the quarter included a $1.27 billion one-time charge to write-off acquired in-process research and development, which is recorded without a tax effect, and excludes the $117.7 million of purchase accounting items discussed above. Excluding these amounts, earnings from operations would have been $118.5 million, a decrease of $65.1 million from the prior year.

Research and development ("R&D") expense for the three months ended December 31, 2007 was $80.8 million compared to $22.9 million in the same prior year period. R&D expense includes approximately $5
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
2. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
3. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
4. Mylan Restores Availability of Generic Levothyroxine in Florida
5. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
6. Mylan Declares Quarterly Preferred Stock Dividend
7. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
8. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
9. Mylan Sets Date of 2008 Annual Meeting
10. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
11. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
(Date:7/29/2015)... ... July 29, 2015 , ... July is National UV Awareness Month, and in honor of this ... on how to protect skin from the sun, as well as how to best treat ... one of the most common skin conditions in America. Many people do not protect their ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Employee Fiduciary, ... will include the general contact information, website, types of plans administered, years in business, ... business listing and have at least one plan with Employee Fiduciary. A search can ...
(Date:7/29/2015)... ... 2015 , ... Attorneys representing American families in national talcum powder lawsuits announce ... features a page dedicated to news related to pending talcum powder lawsuits, as well ... Lawsuit News page was launched with eight initial articles. , “We decided to ...
(Date:7/29/2015)... ... , ... " mybody ” was featured on NewsWatch as part of its ... an impact in their industry. Andrew Tropeano, the host of NewsWatch and business expert, ... are designed to strengthen the skin’s defense system from the inside out. , According ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2
... to help esophageal cancer patients also has been shown to ... The study, using the anti-reflux biliary stent in patients ... the May issue of Gastrointestinal Endoscopy journal. ,This ... its inventor, was cleared for use by FDA last year. ...
... symptom of Parkinson’s disease, according to research//. ... taking antidepressant medications are more likely to develop Parkinson’s ... It found that, in the year before their Parkinson’s ... nearly twice as likely to develop Parkinson’s disease as ...
... of the Mets, a leading baseball team of New York, ... San Francisco to distributing// performance-enhancing drugs to dozens of former ... ,Kirk Radomski, 37, who had worked as a ... banned drugs, including anabolic steroids, amphetamines and human growth hormone, ...
... and the number of injured soldiers is increasing, there is ... ,The Johns Hopkins University Applied Physics Laboratory in ... breakthrough prosthetic arm under the Defense Advanced Research Projects Agency ... an initiative to produce by 2009 a mechanical arm that ...
... used to remove dangerously high levels of lead from ... postural// balance and movement in lead-exposed children. ... found that children treated with succimer (SUX-sim-er) chelation therapy ... perform moving tasks—such as crossing an obstacle or walking—than ...
... study by Stanford scientists may be the first step ... where advanced organ damage// can be repaired by the ... the sea squirt, can correct abnormalities over a series ... be possible in people. ,"We hope ...
Cached Medicine News:Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 2Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 3Health News:Former Official Confesses He Had Sold Steroids to Leading Baseball Players 2Health News:A Realistic Arm on the Anvil for Injured Soldiers 2Health News:Lead Removing Drug Improves Muscle Function in Lead-Exposed Children 2Health News:Scientists Make Major Breakthrough in Regenerative Medicine 2
(Date:7/28/2015)... , July 28, 2015   Heska ... "Company"), a provider of  advanced veterinary diagnostic and ... availability of the new Element i ® ... and screening for key health concerns, including thyroid ... i is a compact bench top analyzer that ...
(Date:7/28/2015)... ALTO, Calif. , July 28, 2015 ... Holding Corp., the parent company of CPI International, Inc. ... third quarter ended July 3, 2015 with the Securities ... regarding its results for the quarter.  At 11 a.m. ... a telephonic conference call in conjunction with this release ...
(Date:7/28/2015)... , July 21, 2015 ... announced the addition of the "Craniomaxillofacial Implants ... Trends and Forecast 2014 - 2022" report ... the craniomaxillofacial implants market studies the current and ... are rapidly gaining popularity in the global market ...
Breaking Medicine Technology:Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3CPI International To Announce Third Quarter 2015 Financial Results 2Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
For the quantitative in vitro determination of Urea in serum, plasma and urine....
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma....
Medicine Products: